The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its BPC 157 aka Wolverine. This peptide is not FDA approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesnt have human data yet, so BPC 157: The peptide with big claims and scant evidence STAT FDA Compliance for Peptide Therapy and BPC 157 Holt Law